BLDE BLADE AIR MOBILITY INC

Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors

Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Strata Critical Medical, Inc. (“Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant industry, today announced the appointment of Will Cook to the Board, effective December 3, 2025. Mr. Cook has also been appointed to the Compensation and Nominating and Corporate Governance Committees.

Mr. Cook is the President and Chief Executive Officer of Vail Health, a nonprofit community health care system headquartered in Vail, Colorado.

“We are very excited to welcome Will Cook to our board of directors,” said Melissa Tomkiel, Strata’s Co-Chief Executive Officer. “Will’s extensive experience in health care will be invaluable to us as we scale our end-to-end organ recovery and logistics platform throughout the country.”

“Will’s deep relationships within, and knowledge of the healthcare industry will be an incredible resource to us as we pursue our mission to increase the number of organs for transplant and explore other avenues to more broadly service the medical sector,” said Will Heyburn, Strata’s Co-Chief Executive Officer.

Prior to Vail Health, Mr. Cook served as President and CEO of University of Colorado Hospital, where he led major facility development projects including two hospitals in northern and southern Denver. Before that, he held senior leadership positions at the University of Pittsburgh Medical Center (UPMC) including Vice President of Transplant and Ambulatory Care at UPMC Presbyterian Shadyside Hospital. He held a variety of roles at Johns Hopkins Health System in Baltimore.

“It’s my honor to serve on the Board of Directors of Strata as we execute against our multi-pronged growth strategy while continuing to facilitate the life-saving work of our customers every day,” said Mr. Cook.

Mr. Cook received a master’s degree in health administration from Washington University School of Medicine and a Bachelor of Arts degree in Business Administration from Texas A&M University.

About Strata Critical Medical, Inc.

Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.

Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

For more information, visit .

Contacts

Mathew Schneider



EN
03/12/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BLADE AIR MOBILITY INC

 PRESS RELEASE

Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors

Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Strata Critical Medical, Inc. (“Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant industry, today announced the appointment of Will Cook to the Board, effective December 3, 2025. Mr. Cook has also been appointed to the Compensation and Nominating and Corporate Governance Committees. Mr. Cook is the President and Chief Executive Officer of Vail Health, a nonprofit community health ...

 PRESS RELEASE

Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Med...

Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Medium-Term Financial Guidance Event highlights multiple ongoing industry growth catalysts and a range of factors that should enable Strata to grow faster than the overall marketTeam defines roll-up opportunity, acquisition philosophy and priority targets for $200 million of estimated cash available for deployment through 2029New 2026 financial guidance and medium-term financial framework targets a sustained high-teens target CAGR(1) for Adjusted EBITDA on an organic basisAdjusted EBITDA expected to double organically(1) by ...

 PRESS RELEASE

Strata Critical Medical Announces Third Quarter 2025 Results

Strata Critical Medical Announces Third Quarter 2025 Results Revenue increased 36.7% year-over-year to $49.3 million in Q3 2025 and grew 29.0% excluding the impact of the Keystone acquisition Net loss increased to $(9.7) million in Q3 2025 versus $(5.6) million in the prior year periodMedical Segment Adjusted EBITDA increased 93.5% in Q3 2025 to $7.6 million versus the prior year period and increased 80.2% excluding the impact of the Keystone acquisition(1)Medical Segment Adjusted EBITDA margin excluding Keystone increased to 15.1% in Q3 2025(1)Raised 2025 revenue guidance to $185-195 milli...

 PRESS RELEASE

Strata Critical Medical Announces Date for Third Quarter Ending Septem...

Strata Critical Medical Announces Date for Third Quarter Ending September 30, 2025 Earnings Release Conference Call NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the third quarter ended September 30, 2025 on Monday, November 10, 2025 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-...

 PRESS RELEASE

Strata Announces 2025 Investor Day

Strata Announces 2025 Investor Day NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE), will hold an Investor Day at the Nasdaq MarketSite in New York City on Monday, November 17th 2025. The event will begin at 2:00pm ET and will include presentations by members of the management team. Investors and analysts can register for the Investor Day on the events section of Strata’s Investor Relations website that can be found . A live video webcast and presentation materia...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch